Jonathan Root's Trading History
| OMDAOmada Health, Inc. | Jul 07, 2026 | Director | Uninformative Buy | ― | $2.90M | |
| CARLCarlsmed, Inc. | Jun 22, 2026 | Director | Uninformative Buy | ― | $89.15M | |
| NARIInari Medical | Feb 19, 2025 | ― | Uninformative Sell | ― | $0.00 | |
| SPRYARS Pharmaceuticals | Mar 18, 2022 | Director | Informative Buy | 36.05K | $6.34M | |
| EWTXEdgewise Therapeutics | Feb 28, 2022 | Director | Uninformative Sell | ― | $703.75K | |
| EFTReFFECTOR Therapeutics | Dec 06, 2021 | Director, Ten Percent Owner | Informative Sell | 46.08K | $90.49K | |
| OMEDOncoMed Pharma | Apr 23, 2019 | ― | Uninformative Sell | ― | $0.00 |
You May Also Like
Jonathan Root insider profile FAQ
What is the percentage of profitable transactions made by Jonathan Root?
The percentage of profitable transactions made by Jonathan Root is 75%.
What is the average return per transaction made by Jonathan Root?
The average return per transaction made by Jonathan Root is 44.70%.
What stocks does Jonathan Root hold?
Jonathan Root holds: EWTX, OMED, NARI, SPRY, EFTR, OMDA, CARL stocks.
What was Jonathan Root's most profitable transaction?
Jonathan Root’s most profitable transaction was an Informative Buy of NARI stock on May 27, 2020. The return on the trade was 106.50%.
What is Jonathan Root's role in Edgewise Therapeutics?
Jonathan Root's role in Edgewise Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.